Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry

J Virol. 2002 Sep;76(18):9335-44. doi: 10.1128/jvi.76.18.9335-9344.2002.

Abstract

Hepatitis C virus-like particles (HCV-LPs) containing the structural proteins of HCV H77 strain (1a genotype) was used as a model for HCV virion to study virus-cell interaction. HCV-LPs showed a buoyant density of 1.17 to 1.22 g/cm(3) in a sucrose gradient and formed double-shelled particles 35 to 49 nm in diameter. Flow cytometry analysis by an indirect method (detection with anti-E2 antibody) and a direct method (use of dye-labeled HCV-LPs) showed that HCV-LPs binds to several human hepatic (primary hepatocytes, HepG2, HuH7, and NKNT-3) and T-cell (Molt-4) lines. HCV-LPs binding to cells occurred in a dose- and calcium-dependent manner and was not mediated by CD81. Scatchard plot analysis suggests the presence of two binding sites for HCV-LPs with high (K(d) approximately 1 microg/ml) and low (K(d) approximately 50 to 60 microg/ml) affinities of binding. Anti-E1 and -E2 antibodies inhibited HCV-LPs binding to cells. While preincubation of HCV-LPs with very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), or high-density lipoprotein (HDL) blocked its binding to cells, preincubation of cells with VLDL, LDL, HDL, or anti-LDL-R antibody did not. Confocal microscopy analysis showed that, after binding to cells, dye-labeled HCV-LPs were internalized into the cytoplasm. This process could be inhibited with anti-E1 or anti-E2 antibodies, suggesting that E1 and E2 proteins mediate HCV-LPs binding and, subsequently, their entry into cells. Altogether, our results indicate that HCV-LPs can be used to further characterize the mechanisms involved in the early steps of HCV infection.

Publication types

  • Evaluation Study

MeSH terms

  • Antigens, CD / metabolism
  • Carcinoma, Hepatocellular
  • Cell Line
  • Hepacivirus / physiology*
  • Hepatocytes / virology*
  • Humans
  • Lipoproteins / pharmacology
  • Membrane Fusion*
  • Membrane Proteins*
  • Microscopy, Confocal
  • T-Lymphocytes / virology*
  • Tetraspanin 28
  • Tumor Cells, Cultured
  • Viral Envelope Proteins / metabolism
  • Virion / physiology*

Substances

  • Antigens, CD
  • CD81 protein, human
  • E1 protein, Hepatitis C virus
  • Lipoproteins
  • Membrane Proteins
  • Tetraspanin 28
  • Viral Envelope Proteins
  • glycoprotein E2, Hepatitis C virus